Company intelligence / Profile preview

Sixthelement

Berkhamsted, Hertfordshire, United Kingdomsixthelement.capital ↗

Ownership: Private
Development stage: Other

Overview

Sixth Element Capital is a UK-based venture capital fund manager specializing in investments in early-stage and growth-stage biotech and health tech companies, with a particular focus on oncology through the CRT Pioneer Fund. The fund bridges the gap between cancer drug discovery and early clinical development by providing creative financing solutions to bring new therapeutic products to market.

Therapeutic areas: Oncology
Industry: Investors

Partnerships

Cancer Research Technology (CRT)

Beyond the preview

Go deeper on Sixthelement.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sixthelement.

Explore the full profile